| Positive Rankings |
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, La Jolla Pharmaceutical Company is ranked 81. |
Up Ratings Revision
During the past month, the average analyst's rating or recommendation has increased. Among companies that have been upgraded within the past month, La Jolla Pharmaceutical Company is ranked 123. |
Low Put/Call
La Jolla Pharmaceutical Company has a low Put/Call ratio of 0.54 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, La Jolla Pharmaceutical Company is ranked 1454. |
10 Day Gain
La Jolla Pharmaceutical Company rank is 2883 |
| Negative Rankings |
90 Day Loss
La Jolla Pharmaceutical Company rank is 120 |
Negative Guidance
Within the past 90 days La Jolla Pharmaceutical Company has provided guidance belwo the consensus estimates. Statistics show companies that provide negative guidance underperform the market in the short-term. |
High vPut/Call
La Jolla Pharmaceutical Company has a high Put/Call ratio of 0.47 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, La Jolla Pharmaceutical Company is ranked 2106. |
